The demand for diagnostic reagents is rising in 2026 because testing has become faster, broader, and more routine across many areas of healthcare. Labs are no longer only running basic panels. They are also managing molecular tests, infectious disease panels, oncology markers, chronic disease monitoring, and point-of-care testing.  This puts pressure on inventory teams. Why?...